References
M.E. Juweid, FDG-PET/CT in lymphoma. Methods Mol Biol. 727, 1–19 (2011). doi:10.1007/978-1-61779-062-1_1
A. Aliyev, S. Ylmaz, M. Ozhan, S. Asa, M. Halac, FDG PET/CT in the detection of metastases in a patient with Tg and 131I WBS negative follicular thyroid cancer. Clin. Nucl. Med. 38(3), 226–227 (2013)
S. Park, S.H. Moon, L.C. Park, D.W. Hwang, J.H. Ji, C.H. Maeng, S.H. Cho, H.K. Ahn, J.Y. Lee, S.J. Kim, J.Y. Choi, W.S. Kim, The impact of baseline and interim PET/CT parameters on clinical outcome in patients with diffuse large B cell lymphoma. Am. J. Hematol. 87(9), 937–940 (2012). doi:10.1002/ajh.23267
P.W. Rosario, G.F. Mourão, T.L. Siman, M.R. Calsolari. Adjuvant therapy with 131-iodine in patients with elevated serum thyroglobulin after reoperation due to papillary thyroid carcinoma lymph node metastases. Endocrine. (2014). doi:10.1007/s12020-014-0414-8
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Guidoccio, F., Grosso, M. & Antonelli, A. Detection of non-Hodgkin lymphoma by [18F]FDG-PET/CT in a patient with differentiated thyroid cancer. Endocrine 50, 260–261 (2015). https://doi.org/10.1007/s12020-014-0485-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-014-0485-6